Sort by

Send to

Choose Destination

Search results

Items: 3


Effect of administration of moxifloxacin plus rifampin against Mycobacterium tuberculosis for 7 of 7 days versus 5 of 7 days in an in vitro pharmacodynamic system.

Drusano GL, Sgambati N, Eichas A, Brown D, Kulawy R, Louie A.

mBio. 2011 Jul 12;2(4):e00108-11. doi: 10.1128/mBio.00108-11. Print 2011.


Use of an in vitro pharmacodynamic model to derive a moxifloxacin regimen that optimizes kill of Yersinia pestis and prevents emergence of resistance.

Louie A, Heine HS, VanScoy B, Eichas A, Files K, Fikes S, Brown DL, Liu W, Kinzig-Schippers M, Sörgel F, Drusano GL.

Antimicrob Agents Chemother. 2011 Feb;55(2):822-30. doi: 10.1128/AAC.00818-10. Epub 2010 Nov 29.


Supplemental Content

Loading ...
Support Center